NICORETTE - NICORETTE GlaxoSmithKline[Brentford England...

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
NICORETTE GlaxoSmithKline [Brentford, England] ranks as the world’s second largest pharmaceutical firm. It markets more than 50 major prescription products across nine major therapeutic classifications.With a world-wide sales volume in excess of $40 billion, GlaxoSmithKline is committed to aggressively continue as a major producer and supplier in the industries and markets in which it competes. With an annual research budget of over $5 billion, GlaxoSmithKline discovers, develops, manufactures and markets a wide range of prescription pharmaceuticals, and over-the-counter (OTC) drug products. To illustrate, the patented Zantac® brand, an anti-ulcer treatment, is a well-known company invention. Consumer products include over-the-counter [OTC] pain relievers such as Ecotrin® and Hedex®, cold medications such as Contact® and Sucrets®, Tums® antacid and Nicorette® smoking cessation products. New York Stock Exchange trading symbol: GSK. Nicorette Stop Smoking Aid (chewing gum) and Nicorette CQ (skin patch) are over-the-counter
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 09/09/2011 for the course MAR 3391 taught by Professor Garcia,s during the Fall '08 term at University of Central Florida.

Ask a homework question - tutors are online